Article Details
Retrieved on: 2021-03-22 22:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibody ... with strong participation from existing investors such as Decheng Capital, SDIC Fund, Sherpa ... KEYWORD: CHINA ASIA PACIFIC.
Article found on: www.oaoa.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here